Clinical Trial
BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group
Affiliations
- PMID: 2506556
Item in Clipboard
Clinical Trial
BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group
Prog Clin Biol Res.
1989.
No abstract available
Similar articles
-
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):10-6. Semin Urol Oncol. 1996. PMID: 8727805 Clinical Trial.
-
BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.Prog Clin Biol Res. 1989;310:285-98. Prog Clin Biol Res. 1989. PMID: 2505272 Clinical Trial. No abstract available.
-
BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.Prog Clin Biol Res. 1988;269:511-24. Prog Clin Biol Res. 1988. PMID: 3134662 Clinical Trial. No abstract available.
-
Intravesical chemotherapy.Prog Clin Biol Res. 1984;162B:125-50. Prog Clin Biol Res. 1984. PMID: 6438639 Review. No abstract available.
-
Treatment of superficial carcinoma of the bladder.Prog Clin Biol Res. 1984;162B:193-209. Prog Clin Biol Res. 1984. PMID: 6209720 Review. No abstract available.
Cited by
-
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.Front Surg. 2021 Nov 23;8:775527. doi: 10.3389/fsurg.2021.775527. eCollection 2021. Front Surg. 2021. PMID: 34888347 Free PMC article.
-
Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer.Cochrane Database Syst Rev. 2000;2000(4):CD001986. doi: 10.1002/14651858.CD001986. Cochrane Database Syst Rev. 2000. PMID: 11034738 Free PMC article.
-
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer.Cochrane Database Syst Rev. 2020 Jan 8;1(1):CD011935. doi: 10.1002/14651858.CD011935.pub2. Cochrane Database Syst Rev. 2020. PMID: 31912907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical